| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 67.0999 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 67.0999. The average price that SDZ.SW shares were previous bought at was CHF 47.9492. The current market price is 39.9% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 111,307 (USD $145,359) compared to the previous valuation of however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 125.85 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 125.85. The average price that MRK.DE shares were previous bought at was EUR 118.299. The current market price is 6.4% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 140,224 (USD $167,957) compared to the previous valuation of Merck KGaA |
| NOVN.SW - | HOLD | 0 @ CHF 124.726 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 124.726. The average price that NOVN.SW shares were previous bought at was CHF 105.242. The current market price is 18.5% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 741,573 (USD $968,440) compared to the previous valuation of however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 49.6023 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 49.6023. The average price that NOVO-B.CO shares were previous bought at was DKK 54.1482. The current market price is -8.4% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 4,309,177 (USD $691,241) compared to the previous valuation of Novo Nordisk A/S |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 70.15 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 70.15. The average price that ORNBV.HE shares were previous bought at was EUR 60.2191. The current market price is 16.5% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 68,887 (USD $82,511) compared to the previous valuation of Orion Oyj |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 24.24 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 24.24. The average price that PHIA.AS shares were previous bought at was EUR 22.5066. The current market price is 7.7% higher than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 118,255 (USD $141,643) compared to the previous valuation of Koninklijke Philips NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 46.48 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 46.48. The average price that REC.MI shares were previous bought at was EUR 52.4932. The current market price is -11.5% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 49,857 (USD $59,718) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 384.831 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 384.831. The average price that RO.SW shares were previous bought at was CHF 308.354. The current market price is 24.8% higher than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 225,652 (USD $294,685) compared to the previous valuation of however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 378.72 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 378.72. The average price that ROG.SW shares were previous bought at was CHF 292.991. The current market price is 29.3% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 6,660,055 (USD $8,697,541) compared to the previous valuation of however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 77.08 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 77.08. The average price that SAN.PA shares were previous bought at was EUR 86.7193. The current market price is -11.1% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 457,975 (USD $548,552) compared to the previous valuation of Sanofi SA |
| LONN.SW - | HOLD | 0 @ CHF 582.813 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 582.813. The average price that LONN.SW shares were previous bought at was CHF 603.654. The current market price is -3.5% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 779,291 (USD $1,017,697) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 42.05 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 42.05. The average price that SHL.DE shares were previous bought at was EUR 47.0975. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 128,425 (USD $153,825) compared to the previous valuation of Siemens Healthineers AG |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.0016 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.0016. The average price that SN.L shares were previous bought at was GBP 13.7289. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 120,084 (USD $166,020) compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 31.8023 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.8023. The average price that SOBI.ST shares were previous bought at was SEK 27.0618. The current market price is 17.5% higher than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 62,018 (USD $7,035) compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 229.742 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 229.742. The average price that SOON.SW shares were previous bought at was CHF 259.181. The current market price is -11.4% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 15,650 (USD $20,438) compared to the previous valuation of |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 241.1 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 241.1. The average price that SRT3.DE shares were previous bought at was EUR 219.226. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 218,399 (USD $261,593) compared to the previous valuation of Sartorius AG |
| STMN.SW - | HOLD | 0 @ CHF 99.9951 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 99.9951. The average price that STMN.SW shares were previous bought at was CHF 109.628. The current market price is -8.8% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 177,938 (USD $232,374) compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 214.5 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 214.5. The average price that TUB.BR shares were previous bought at was EUR 220.6. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in TUB.BR has fallen by EUR 9,016 (USD $10,799) compared to the previous valuation of Financiere de Tubize SA |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 253 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 253. The average price that UCB.BR shares were previous bought at was EUR 193.596. The current market price is 30.7% higher than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 34,258 (USD $41,033) compared to the previous valuation of UCB SA |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 37.43 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 37.43. The average price that FME.DE shares were previous bought at was EUR 45.5278. The current market price is -17.8% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 31,884 (USD $38,190) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 710 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 710. The average price that ARGX.BR shares were previous bought at was EUR 591.546. The current market price is 20.0% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 11,098 (USD $13,293) compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 155.304 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 155.304. The average price that AZN.L shares were previous bought at was GBP 133.626. The current market price is 16.2% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 920,491 (USD $1,272,609) compared to the previous valuation of AstraZeneca PLC |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 44.015 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 44.015. The average price that BAYN.DE shares were previous bought at was EUR 26.4621. The current market price is 66.3% higher than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 1,042,433 (USD $1,248,602) compared to the previous valuation of Bayer AG |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 97.75 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 97.75. The average price that BIM.PA shares were previous bought at was EUR 113.695. The current market price is -14.0% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 57,582 (USD $68,970) compared to the previous valuation of BioMerieux |
| COLO-B.CO - | HOLD | 0 @ DKK 72.5019 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 72.5019. The average price that COLO-B.CO shares were previous bought at was DKK 82.6943. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 121,513 (USD $19,492) compared to the previous valuation of however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 29.4346 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.4346. The average price that DEMANT.CO shares were previous bought at was DKK 32.2206. The current market price is -8.6% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 18,827 (USD $3,020) compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 191.45 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 191.45. The average price that DIM.PA shares were previous bought at was EUR 193.813. The current market price is -1.2% lower than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 160,053 (USD $191,708) compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 254.6 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 254.6. The average price that EL.PA shares were previous bought at was EUR 263.653. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 352,720 (USD $422,480) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 66.2 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 66.2. The average price that ERF.PA shares were previous bought at was EUR 58.3524. The current market price is 13.4% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 470,885 (USD $564,015) compared to the previous valuation of Eurofins Scientific SE |
| ALC.SW - | HOLD | 0 @ CHF 67.5147 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 67.5147. The average price that ALC.SW shares were previous bought at was CHF 73.5684. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 113,939 (USD $148,796) compared to the previous valuation of however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 46.67 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 46.67. The average price that FRE.DE shares were previous bought at was EUR 43.0226. The current market price is 8.5% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 373,897 (USD $447,845) compared to the previous valuation of Fresenius SE & Co KGaA |
| GALD.SW - | HOLD | 0 @ CHF 155.963 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 155.963. The average price that GALD.SW shares were previous bought at was CHF 133.102. The current market price is 17.2% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 152,340 (USD $198,945) compared to the previous valuation of |
| GMAB.CO - | HOLD | 0 @ DKK 276.804 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 276.804. The average price that GMAB.CO shares were previous bought at was DKK 213.077. The current market price is 29.9% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 130,964 (USD $21,008) compared to the previous valuation of however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.755 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.755. The average price that GRF.MC shares were previous bought at was EUR 10.6961. The current market price is 0.6% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 58,956 (USD $70,616) compared to the previous valuation of Grifols SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 21.3688 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 21.3688. The average price that GSK.L shares were previous bought at was GBP 17.621. The current market price is 21.3% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 1,406,511 (USD $1,944,548) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2026-01-29 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 17.5035 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.5035. The average price that HIK.L shares were previous bought at was GBP 22.1711. The current market price is -21.1% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 29,664 (USD $41,011) compared to the previous valuation of |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.2876 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.2876. The average price that HLN.L shares were previous bought at was GBP 4.39217. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 106,554 (USD $147,314) compared to the previous valuation of Haleon PLC |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 136.6 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 136.6. The average price that IPN.PA shares were previous bought at was EUR 111.788. The current market price is 22.2% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 37,499 (USD $44,915) compared to the previous valuation of Ipsen SA |